Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

Garcia Maria Jose, Riestra Sabino, Amiot Aurelien, Julsgaard Mette, Garcia de la Filia Irene, Calafat Margalida, Aguas Mariam, de la Pena Luisa, Roig Cristina, Caballol Berta, Casanova Maria Jose, Farkas Klaudia, Boysen Trine, Bujanda Luis, Cuaran Camila, Dobru Daniela, Fousekis Fotios, Gargallo-Puyuelo Carla Jerusalen, Savarino Edoardo, Calvet Xavier, Huguet Jose Maria, Kupcinskas Limas, Lopez-Cardona Julia, Raine Tim, van Oostrom Joep, Gisbert Javier P., Chaparro Maria
2024

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease A Retrospective, Multicentre Study /

Farkas Bernadett, Bessissow Talat, Limdi Jimmy K., Sethi-Arora Karishma, Kagramanova Anna, Knyazev Oleg, Bezzio Cristina, Armuzzi Alessandro, Lukas Milan, Michalopoulos George, Chaskova Elena, Savarino Edoardo Vincenzo, Castiglione Fabiana, Rispo Antonio, Schäfer Eszter, Saibeni Simone, Filip Rafal, Attauabi Mohamed, Fousekis Fotios S., Bacsur Péter, Resál Tamás, Bálint Anita, Ivány Emese, Szepes Zoltán, Bősze Zsófia, Fábián Anna, Bor Renáta, Farkas Klaudia, Lakatos Péter László, Molnár Tamás
2024